What if our blood could help us detect cancer earlier than ever before?
In this episode, we’re asking the big questions around liquid biopsies, cutting-edge blood tests that can pick up the smallest signs of cancer swirling through the blood. We sit down with Professor Nitzan Rosenfeld, Director of Barts Cancer Institute and a pioneer in the field.
Professor Rosenfeld explains how fragments of tumour DNA enter our blood from cancer cells, what they can tell us about cancer, and how liquid biopsies can use blood samples to transform early detection, screening and treatment.
Cancer blood tests are much less invasive than surgical biopsies, and they can reveal what’s happening in the body in much more detail than scans. They’re most valuable when combined with other tools, but their potential is clear. Just as our blood flows through every part of our body, blood tests could reshape almost every part of cancer care.
